B.C. Pharmacare Program Expands Coverage to Include Diabetes and Menopause Treatments
British Columbia has significantly expanded its pharmacare program, now offering full coverage for diabetes medications and menopausal therapies to hundreds of thousands of residents. This expansion follows a federal-provincial agreement signed last year that integrated B.C. into the national pharmacare framework.
Comprehensive Coverage for Critical Health Needs
Starting March 1, the pharmacare program now covers most diabetes drugs and menopausal treatments in their entirety, regardless of income levels. This represents a substantial enhancement to the existing coverage that already included most prescription drugs with cost-sharing based on income.
The newly covered medications include:
- All eligible diabetes medications for both Type 1 and Type 2 diabetes
- Hormonal therapies for menopause symptoms
- Contraceptives (which have been free in B.C. since 2023)
Diabetes Canada estimates that managing Type 1 diabetes can cost up to $18,300 annually, while Type 2 diabetes treatment may reach $10,000 per year. Menopause hormone therapies—including estrogen pills, patches, and gels—typically range from $240 to $1,800 annually without insurance coverage.
Who Benefits from the Expanded Coverage
The expanded pharmacare coverage is expected to benefit approximately 570,000 British Columbians living with diabetes and about 160,000 individuals requiring menopause therapy. The coverage is automatic, requiring no additional enrollment for eligible residents.
For other prescription medications, the pharmacare program continues to operate on an income-based model. The amount covered depends on family income, with deductibles increasing as income rises. For example:
- Families earning $50,000 annually receive coverage after spending $1,500 on prescriptions
- The program pays 70% of drug costs up to $2,000, then 100% beyond that threshold
- Families with $100,000 income have a $3,000 deductible before coverage begins
- Full coverage activates after $4,000 in prescription spending for higher-income families
Specific Medications and Coverage Details
The covered diabetes medications now include insulin, metformin, sulfonylureas (such as glyburide and gliclazide), dapagliflozin, empagliflozin, saxagliptin, linagliptin, and pioglitazone. Some medications require special approval through the program's authorization process.
It's important to note that semaglutides like Ozempic—frequently used for weight loss—are only covered under "special authority" when prescribed specifically for diabetes treatment after other therapies prove ineffective. While B.C. has approved Wegovy for weight management under pharmacare, it doesn't receive the same full coverage as diabetes medications.
The federal-provincial agreement that enabled this expansion was signed on March 6, 2025, establishing the framework for comprehensive prescription drug coverage across the province. Residents can access the complete list of covered medications and program details through official government websites.
